The company plans to manufacture a rare, radioactive isotope for use in cancer treatment trials starting in 2029.
Greg Daugherty has worked 25+ years as an editor and writer for major publications and websites. He is also the author of two books. David Kindness is a Certified Public Accountant (CPA) and an expert ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results